Updated: January 17, 2026
Alternatives to Insulin, Human Isophane (NPH) If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Important: Never Switch Insulin Without Medical Guidance
- Option 1: Switch Between NPH Brands (Humulin N ↔ Novolin N)
- Option 2: Insulin Glargine (Lantus, Basaglar, Semglee, Toujeo)
- Option 3: Insulin Degludec (Tresiba)
- Option 4: Regular Human Insulin (Humulin R, Novolin R) as Temporary Bridge
- How to Talk to Your Doctor About Switching
- Finding NPH Insulin Before Considering a Switch
If you can't find NPH insulin (Humulin N or Novolin N) at your pharmacy, there are alternatives. Learn what your options are and how to switch safely.
If your pharmacy is out of NPH insulin — sold as Humulin N, Novolin N, or Walmart's ReliOn N — you may be wondering what your options are. The good news is that there are several alternatives to insulin, human isophane that your doctor can consider. The critical rule is this: never switch insulin types on your own. Any transition must be managed by your prescriber with careful blood sugar monitoring.
Important: Never Switch Insulin Without Medical Guidance
Different insulins have very different onset times, peak effects, and durations of action. What works as a 1-for-1 switch in some cases requires significant dose adjustments in others. Switching insulin types without guidance can cause dangerously low blood sugar (hypoglycemia) or out-of-control high blood sugar (hyperglycemia). Always call your prescriber before making any change.
Option 1: Switch Between NPH Brands (Humulin N ↔ Novolin N)
The simplest alternative is switching between the two main brands of NPH insulin: Humulin N (Eli Lilly) and Novolin N (Novo Nordisk). Both contain the same active ingredient — insulin isophane human — and have the same pharmacological profile. Your prescriber or pharmacist can often authorize this switch quickly.
Key differences to be aware of:
- Opened vial storage: Humulin N can be stored at room temperature for up to 31 days; Novolin N for up to 42 days.
- Excipients: The inactive ingredients differ slightly between manufacturers. Patients with known sensitivities should discuss with their pharmacist.
- Walmart ReliOn N: ReliOn Novolin N is the same as Novolin N and is available OTC for ~$25/vial.
Option 2: Insulin Glargine (Lantus, Basaglar, Semglee, Toujeo)
Insulin glargine is a long-acting basal insulin analog and the most common modern alternative to NPH. Unlike NPH's intermediate 12-24 hour action, glargine provides a flatter, more consistent blood sugar-lowering effect lasting approximately 24 hours. This translates to lower risk of nocturnal hypoglycemia compared to NPH.
The 2025 ADA Standards of Care confirm that long-acting basal analogs like glargine reduce the risk of nocturnal hypoglycemia compared to NPH insulin in clinical trials.
Common glargine brands and pricing:
- Lantus (Sanofi): Brand name; widely available; $35/month cap through Sanofi savings program.
- Basaglar (Eli Lilly): Biosimilar to Lantus; $35/month cap through Lilly Insulin Value Program.
- Semglee (Viatris): FDA-designated interchangeable biosimilar to Lantus; note that Semglee vials and pens were discontinued by Biocon as of December 31, 2025; generic glargine vials/pens from other manufacturers remain available.
Important: Switching from NPH to glargine is not a straight unit-for-unit switch in all patients. Your doctor may reduce your starting glargine dose by 10-20% and adjust based on blood glucose monitoring.
Option 3: Insulin Degludec (Tresiba)
Insulin degludec (Tresiba) is an ultra-long-acting basal insulin with a duration of action over 42 hours. It has a very flat pharmacokinetic profile — meaning blood sugar control is highly consistent from day to day. It also carries a lower nocturnal hypoglycemia risk than NPH.
However, as of early 2026, Tresiba itself has been experiencing intermittent supply constraints, particularly in the U-200 formulation. Check availability with your pharmacy before requesting a switch to degludec.
Option 4: Regular Human Insulin (Humulin R, Novolin R) as Temporary Bridge
Regular insulin (short-acting) is also available OTC at Walmart under the ReliOn brand. In an emergency, a prescriber may instruct you to use regular insulin on a different dosing schedule as a very short-term bridge. This is not a routine substitution — it requires very different injection timing and monitoring.
How to Talk to Your Doctor About Switching
When you call your prescriber, be ready to share:
- Your current NPH dose (units and frequency).
- How many days of supply you have left.
- Which pharmacies are out of your usual NPH brand.
- Whether you can access Walmart's ReliOn N (about $25/vial) if cost is a factor.
Finding NPH Insulin Before Considering a Switch
Before switching insulin types, make sure you have truly exhausted options for finding your NPH insulin. medfinder calls pharmacies near you to check stock — you might find your brand at a pharmacy a few miles away that you haven't tried yet. See also: How to Find NPH Insulin In Stock Near You.
Frequently Asked Questions
Humulin N and Novolin N contain the same active ingredient (NPH insulin) and have the same pharmacological profile. In most cases, your prescriber or pharmacist can authorize the switch. They have slightly different storage requirements once opened (31 days vs. 42 days at room temp), so review instructions carefully when switching brands.
Insulin glargine is a common long-acting analog alternative to NPH, with a flatter profile and lower nocturnal hypoglycemia risk. However, the switch is not automatically unit-for-unit — your doctor typically starts glargine at a dose 10-20% lower and adjusts based on blood glucose monitoring. Never switch on your own without medical supervision.
If you are running critically low on NPH insulin, call your prescriber immediately. They can authorize an emergency brand switch or alternative. For uninsured patients, Walmart's ReliOn Novolin N (~$25/vial OTC) is often the fastest no-prescription backup option. Never skip doses while waiting.
NPH is intermediate-acting with a more pronounced peak, which can cause greater variability in blood sugar — including nocturnal hypoglycemia. Insulin glargine has a flatter, more predictable profile and a lower hypoglycemia risk in clinical trials. However, NPH is older, less expensive, available OTC, and still clinically appropriate for many patients, especially when cost is a primary concern.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Insulin, Human Isophane also looked for:
More about Insulin, Human Isophane
36,651 have already found their meds with Medfinder.
Start your search today.





